Cough and Expiratory Training for Pneumonia Risk after Head and Neck Cancer Treatment
Trial Summary
What is the purpose of this trial?
The goal of this clinical research study is to learn if exercising the muscles that help you cough and swallow, called expiratory muscle strength training (EMST), can help reduce the risk of pneumonia due to aspiration (inhaling saliva instead of swallowing it) in patients who have had radiation for head and neck cancer.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Expiratory Muscle Strength Training (EMST) Device for pneumonia risk after head and neck cancer treatment?
Research shows that Expiratory Muscle Strength Training (EMST) can improve swallowing function and airway safety in patients who have undergone radiation for nasopharyngeal carcinoma, suggesting it may help reduce pneumonia risk by strengthening the muscles involved in breathing and swallowing.12345
Is Expiratory Muscle Strength Training (EMST) safe for humans?
How is the Expiratory Muscle Strength Training (EMST) treatment different from other treatments for pneumonia risk after head and neck cancer treatment?
The Expiratory Muscle Strength Training (EMST) treatment is unique because it is a simple, device-driven exercise therapy that strengthens the muscles used for breathing out, which can help improve cough function and swallowing. Unlike other treatments, it is non-invasive, can be done at home, and specifically targets respiratory muscle strength to reduce aspiration risk, which is a common issue after head and neck cancer treatment.34789
Research Team
Katherine A. Hutcheson
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for adults who've had radiation therapy at MDACC for new primary head and neck cancer within the last 15 years, need a swallowing evaluation, can consent to participate, and have no history of certain surgeries or recurrent cancers. Those with severe cognitive impairment, tracheotomy, oxygen dependence, or major heart/lung/muscle diseases cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the EMST device at home on a 5-5-5 schedule for 8 weeks, with weekly visits to adjust device resistance and measure expiratory function.
Follow-up Visit
Participants undergo functional testing and complete questionnaires about symptoms and quality of life.
Follow-up Call
Participants are contacted by phone to complete questionnaires about symptoms, health, and quality of life.
Treatment Details
Interventions
- Expiratory Muscle Strength Training (EMST) Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
IRG
Collaborator